SCHEMBL7560898

SCHEMBL7560898

CCc1ccc(C=NNC(=O)c2[nH]c3ccccc3c2C(C)C)o1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.45
ALDH1A1 P00352 3/20 0.45
ALPG P10696 1/20 0.45
KMT2A Q03164 10/20 0.41
MEN1 O00255 9/20 0.41
POLB P06746 6/20 0.41
KDM4E B2RXH2 2/20 0.41
GBA1 P04062 1/20 0.41
LMNA P02545 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
THRB P10828 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 2/20 0.39
HTT P42858 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7560894 1.00 MAPT (0.45) MAPTALDH1A1ALPGKMT2AMEN1
SCHEMBL7562433 0.87 ALDH1A1 (0.61) MAPTALDH1A1ALPGKMT2AMEN1
SCHEMBL7562436 0.87 ALDH1A1 (0.61) MAPTALDH1A1ALPGKMT2AMEN1
SCHEMBL7560462 0.84 GAA (0.55) MAPTALDH1A1ALPGKMT2AMEN1
SCHEMBL7560458 0.84 GAA (0.55) MAPTALDH1A1ALPGKMT2AMEN1
SCHEMBL7558170 0.82 TDP1 (0.54) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL7558176 0.82 TDP1 (0.54) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL7559728 0.82 SMN1; SMN2 (0.57) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL7559725 0.82 SMN1; SMN2 (0.57) MAPTALDH1A1KMT2AMEN1POLB
SCHEMBL7566762 0.81 MAPK1 (0.61) MAPTALDH1A1KMT2APOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US claimed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO claimed
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAPT 4828/4885ALDH1A1 98/4885ALPG 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.